Mexico - Latin America Real Time Pcr, Digital Pcr, And End Point Pcr Market Size & Outlook
The real time pcr, digital pcr, and end point pcr market in Mexico - Latin America is expected to reach a projected revenue of US$ 66.3 million by 2030. A compound annual growth rate of 6.3% is expected of Mexico - Latin America real time pcr, digital pcr, and end point pcr market from 2024 to 2030.
Clinical Diagnostics
In Vitro Diagnostics
Real Time PCR, Digital PCR, And End Point PCR Market Outlook
Mexico real time pcr, digital pcr, and end point pcr market highlights
The Mexico real time pcr, digital pcr, and end point pcr market generated a revenue of USD 43.2 million in 2023 and is expected to reach USD 66.3 million by 2030.
The Mexico market is expected to grow at a CAGR of 6.3% from 2024 to 2030.
In terms of segment, quantitative was the largest revenue generating technology in 2023.
Digital is the most lucrative technology segment registering the fastest growth during the forecast period.
Real time pcr, digital pcr, and end point pcr market data book summary
Market revenue in 2023
USD 43.2 million
Market revenue in 2030
USD 66.3 million
Growth rate
6.3% (CAGR from 2023 to 2030)
Largest segment
Quantitative
Fastest growing segment
Digital
Historical data
2018 - 2022
Base year
2023
Forecast period
2024 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Quantitative, Digital, End-point
Key market players worldwide
Abbott Laboratories, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, GE Aerospace, BioMerieux SA, Roche Holding AG ADR, Fluidigm Corporation
Other key industry trends
In terms of revenue, Mexico accounted for 0.6% of the global real time pcr, digital pcr, and end point pcr market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Latin America, Brazil real time pcr, digital pcr, and end point pcr market is projected to lead the regional market in terms of revenue in 2030.
Brazil is the fastest growing regional market in Latin America and is projected to reach USD 130.4 million by 2030.
According to WHO’s health report on cancer, Unhealthy dietary habits, less physical inactivity, and insufficient awareness about lifestyle-induced disorders are expected to increase the incidence of diseases.
Furthermore, the geriatric population in Mexico is growing rapidly, which is expected to increase the incidence of cardiovascular diseases. Favorable research initiatives and the increasing number of agreements between key companies are likely to boost the market over the forecast period.
For instance, in November 2021, Seegene, Inc. opened a new subsidiary for advancement in COVID-19 testing in Bogotá, Colombia. Moreover, in April 2022, Hygiena launched a RapidScreen test for detecting microbial contamination, with increasing demand for PCR, enabling the overall market expansion.
Mexico - Latin America Real Time PCR, Digital PCR, And End Point PCR Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Real Time PCR, Digital PCR, And End Point PCR Market Outlook will help companies and investors design strategic landscapes.
Quantitative was the largest segment with a revenue share of 81.25% in 2023.
Horizon Databook has segmented the Mexico - Latin America real time pcr, digital pcr, and end point pcr market based on quantitative, digital, end-point covering the revenue growth of each sub-segment from 2018 to 2030.
According to WHO’s health report on cancer, Unhealthy dietary habits, less physical inactivity, and insufficient awareness about lifestyle-induced disorders are expected to increase the incidence of diseases.
Furthermore, the geriatric population in Mexico is growing rapidly, which is expected to increase the incidence of cardiovascular diseases. Favorable research initiatives and the increasing number of agreements between key companies are likely to boost the market over the forecast period.
For instance, in November 2021, Seegene, Inc. opened a new subsidiary for advancement in COVID-19 testing in Bogotá, Colombia. Moreover, in April 2022, Hygiena launched a RapidScreen test for detecting microbial contamination, with increasing demand for PCR, enabling the overall market expansion.
Mexico - Latin America Real Time Pcr, Digital Pcr, And End Point Pcr Market Technology Outlook (Revenue, USD Million , 2018-2030)
Quantitative
Digital
End-point
Mexico - Latin America Real Time Pcr, Digital Pcr, And End Point Pcr Market Product Outlook (Revenue, USD Million , 2018-2030)
Consumables & Reagents
Instruments
Software & Services
Mexico - Latin America Real Time Pcr, Digital Pcr, And End Point Pcr Market Application Outlook (Revenue, USD Million , 2018-2030)
Clinical
Research
Forensic
Reasons to subscribe to Real Time PCR, Digital PCR, And End Point PCR Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Real Time PCR, Digital PCR, And End Point PCR Market Outlook databook
Our clientele includes a mix of Real Time PCR, Digital PCR, And End Point PCR Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico - Latin America Real Time PCR, Digital PCR, And End Point PCR Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Mexico - Latin America Real Time PCR, Digital PCR, And End Point PCR Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Mexico - Latin America Real Time Pcr, Digital Pcr, And End Point Pcr Market, 2018-2030 (US$M)